•
Sep 30, 2022

AN2 Therapeutics Q3 2022 Earnings Report

EPS
-$0.59
Previous year: -$3.36
-82.4%
Cash and Equivalents
$28.8M
Previous year: $15.8M
+82.1%
Total Assets
$110M

AN2 Therapeutics

AN2 Therapeutics